AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

CUSIP: 03152W109

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+6,181,260
Put/Call ratio
156%
SEC-reported price per share
$11.09
Number of holders
222
Value change
+$66,985,676
Number of buys
123
Open additional details 1 more signal available
Number of sells
81
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
316,644,581

Security key

03152W109

Report period

Q1 2023

Institutions

222

Top holders

10

Ownership snapshot

Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $337,520,017 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $337.52M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $337.52M
Avoro Capital Advisors LLC $327.23M
VANGUARD GROUP INC $324.03M
Redmile Group, LLC $247.25M
BlackRock Finance, Inc. $245.89M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$337,520,017
27,642,917 shares
— 31 Dec 2022
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$327,228,000
26,800,000 shares
— 31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$324,033,510
26,538,371 shares
— 31 Dec 2022
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$247,249,924
20,249,789 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$245,885,933
20,138,078 shares
— 31 Dec 2022
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$217,818,511
17,839,354 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
222
Shares
297,533,564
Rows available
222
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
222
Q1 2023 holders
222
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .